Terms: = Skin cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
591 results:
1. Joinpoint regression analysis of recent trends in desmoplastic malignant melanoma incidence and mortality: 15-year multicentre retrospective study.
Yu H; Zhu L; Zhang J; Zheng S; Ming WK; Ip CC; Jiang Y; Chen W; Wu S; Lyu J; Deng L
Arch Dermatol Res; 2024 May; 316(6):273. PubMed ID: 38796649
[TBL] [Abstract] [Full Text] [Related]
2. Head and neck reconstruction with the superficial circumflex iliac artery perforator (SCIP) free flap: Lessons learned after 73 cases.
Scaglioni MF; Meroni M; Tomasetti PE; Rajan GP
Head Neck; 2024 Jun; 46(6):1428-1438. PubMed ID: 38533771
[TBL] [Abstract] [Full Text] [Related]
3. Incidence of Nonmelanoma skin cancers in Alberta, Canada, From 2007 to 2018.
Chambers DB; Ghosh S; Taher MS; Salopek TG
J Cutan Med Surg; 2024; 28(3):238-247. PubMed ID: 38374688
[TBL] [Abstract] [Full Text] [Related]
4. Pachydysostosis of the fibula in a case of familial adenomatous polyposis.
Oliveira D; Maia S; Balacó I; Coelho P; Almeida S; Venâncio M; Saraiva J; Nishimura G; Sousa SB
Eur J Med Genet; 2024 Apr; 68():104913. PubMed ID: 38286305
[TBL] [Abstract] [Full Text] [Related]
5. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
[TBL] [Abstract] [Full Text] [Related]
6. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
[TBL] [Abstract] [Full Text] [Related]
7. Global, Regional, and National Incidence Trend Analysis of Malignant skin Melanoma Between 1990 and 2019, and Projections Until 2034.
Yuan J; Li X; Yu S
Cancer Control; 2024; 31():10732748241227340. PubMed ID: 38227397
[TBL] [Abstract] [Full Text] [Related]
8. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
9. Melanocytic Neoplasm With KIT and apc Mutations: A New Subtype of Melanocytoma?
Donati M; Grossmann P; Mansour B; Kazakov DV
Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
[TBL] [Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Pham JP; Rodrigues A; Goldinger SM; Sim HW; Liu J
Exp Dermatol; 2024 Jan; 33(1):e14978. PubMed ID: 37971204
[TBL] [Abstract] [Full Text] [Related]
11. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
12. Comparative age-period-cohort analysis.
Rosenberg PS; Miranda-Filho A; Whiteman DC
BMC Med Res Methodol; 2023 Oct; 23(1):238. PubMed ID: 37853346
[TBL] [Abstract] [Full Text] [Related]
13. Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran.
Bashari N; Safaei Lari M; Darvishi A; Daroudi R
Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):273-284. PubMed ID: 37750606
[TBL] [Abstract] [Full Text] [Related]
14. Telomere length is associated with increased risk of cutaneous melanoma: a Mendelian randomization study.
Liu M; Lan Y; Zhang H; Zhang X; Wu M; Yang L; Zhou J; Tong M; Leng L; Zheng H; Li J; Mi X
Melanoma Res; 2023 Dec; 33(6):475-481. PubMed ID: 37650705
[TBL] [Abstract] [Full Text] [Related]
15. Dermatofibroma Versus Dermatofibrosarcoma Protuberans: A Nuclear Morphology Study.
Khamdan F; Brailsford C; Dirr MA; Sagut P; Nietert PJ; Elston D
Am J Dermatopathol; 2023 Sep; 45(9):631-634. PubMed ID: 37625803
[TBL] [Abstract] [Full Text] [Related]
16. Open Versus Core Needle Biopsy in Lower-Extremity Sarcoma: Current Practice Patterns and Patient Outcomes.
Burke ZDC; Lazarides AL; Gundavda MK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):57-64. PubMed ID: 37466581
[TBL] [Abstract] [Full Text] [Related]
17. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
[TBL] [Abstract] [Full Text] [Related]
18. Current Patterns of Treatment and Outcomes in Advanced Melanoma at a Single Institution.
Rose MA; Miura J; Sharon C; Ermer JP; Karakousis G; Wachtel H
J Surg Res; 2023 Nov; 291():25-33. PubMed ID: 37331189
[TBL] [Abstract] [Full Text] [Related]
19. HLA-B27 positivity in a large miscegenated population of 5,389,143 healthy blood marrow donors in Brazil.
Resende GG; Saad CGS; de Oliveira DCM; de Sousa Bueno Filho JS; Sampaio-Barros PD; de Medeiros Pinheiro M
Adv Rheumatol; 2023 Apr; 63(1):16. PubMed ID: 37081582
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of statistical models to predict age-standardized cancer incidence in Switzerland.
Trächsel B; Rousson V; Bulliard JL; Locatelli I
Biom J; 2023 Oct; 65(7):e2200046. PubMed ID: 37078835
[TBL] [Abstract] [Full Text] [Related]
[Next]
